Press Archive

Get up to speed reading all the news from the past and the present. 

Date
 		 Title
 
Dec 5, 2006 NuGEN Launches 2 New Products: The Ovation™ Whole Blood Solution and the Ovation™ RNA Amplification System V2
Oct 16, 2006 Beckman Coulter Subsidiary, Agencourt Bioscience, Enters Into Supply Agreement with NuGEN
Sept 26, 2006 Expression Analysis Adopts NuGEN's Ovation™ System for Small-Sample Amplification
Sept 18, 2006 NuGEN Launches Two New Products: The WT-Ovation™ Pico RNA Amplification System and the FL-Ovation™ cDNA Biotin Module V2
Jun 21, 2006 NuGEN Technologies Announces Appointment of Dr. Garry Miyada as Vice President of Product Development; Industry leader extends NuGEN's depth of expertise in gene expression and analysis
May 3, 2006 NuGEN announces Co-Marketing Agreement with QIAGEN Targeting RNA Amplification and Analysis; Agreement to provide complete solutions for RNA isolation and analysis
Apr 26, 2006 NuGEN's Ovation™ Biotin System Enables Gene Expression Analysis in Human Whole Blood Samples Without the Need for Globin Reduction; Application note details improved performance and specificity of cDNA targets over traditional methods
Mar 21, 2006 NuGEN Technologies Announces Addition of Industry Veteran Dr. Michael Hunkapiller to Board of Directors; Company closes $7.75 million funding round led by Alloy Ventures
Feb 7, 2006 NuGEN Technologies Expands International Presence with Two New Distributors and Increased Sales Presence in Europe
Dec 12, 2005 NuGEN Technologies Expands Management Team with Three New Appointments, Company adds CFO, VP Commercial Operations and Senior Director of Customer Solutions
Sept 20, 2005 NuGEN Granted Patent for RNA Amplification Technology
Sept 12, 2005 NuGEN Technologies Appoints Elizabeth A. Hutt Chief Executive Officer, Anne R. Kopf-Sill Promoted to Senior Vice President of Product Development and Operations
Sept 7, 2005 NuGEN Announces Launch of WT-Ovation™ RNA Amplification System; Enables Analysis Across the Entire Transcriptome Without 3' Bias
Mar 8, 2005 NuGEN Enters Into Collaboration with Consortium of Healthcare Organizations
Feb 1, 2005 NuGEN announces OPENING OF EUROPEAN SALES OFFICE AND international sales initiative with MediBIC
Nov 9, 2004 NuGEN Strengthens Intellectual Property Portfolio and Expands Protection for Nucleic Acid Technologies
Oct 5, 2004 NuGEN Announces the Adoption of the Ovation™ Biotin System by Top-Ranked Institution
Sept 14, 2004 NuGEN launches the Ovation™ RNA Amplification System For Gene Expression Analysis
Jul 20, 2004 Ovation™ System to Be Implemented by Cincinnati Children's Hospital Affymetrix Microarray Core Facility as Standard RNA Amplification and Labeling System
Jun 29, 2004 Ovation™ System to Be Implemented by Premier San Francisco Research Institution's Microarray Core Facility, as Standard RNA Amplification and Labeling System
Apr 21, 2004 University of Rochester's Microarray Core Facility to Implement Ovation™ System as Standard RNA Amplification and Labeling System
Mar 15, 2004 NuGEN Strengthens IP Portfolio with Issuance of Two U.S. Patents
Mar 9, 2004 NuGEN Launches the Ovation™ Biotin System for Affymetrix GeneChip® Arrays
Feb 5, 2004 NuGEN Expands Management Team with Three New Appointments
Dec 10, 2003 Affymetrix and NuGEN Collaborate to Advance Whole Transcript Analysis
Nov 12, 2003 Ribo-SPIA™ Process Utilized in Gene Expression Profiling Study Investigating Possible Causes of Parkinson's Disease
Oct 29, 2003 NuGEN Technologies Debuts Biotin Version of the Ovation™ System at Chips to Hits
Oct 7, 2003 NuGEN Awarded NIH Grant for Development of Enabling Technologies for Gene Expression Profiling
Mar 18, 2003 NuGEN Launches New Product: Ovation™ Aminoallyl System
Oct 28, 2002 New Ribo-SPIA™ Gene Expression Amplification Technology makes the Most of Very Small Samples
Oct 15, 2002 NuGEN and Genome of Singapore Enter Research Collaboration
Aug 5, 2002 NuGEN Awarded SBIR Grant to Develop a Rapid, High Sensitivity Test for Anthrax
Jun 26, 2001 NuGEN Receives Key Patent Covering Important DNA Analysis Technology